Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Warning Letters
Manufacturing
FDA cites complaint-plagued Cipla facility in scathing report
Cipla has been hit with a scathing 23-page Form 483 in the wake of an FDA inspection of one of its manufacturing facilities in India.
Joseph Keenan
Mar 7, 2023 9:35am
Amneal plant slapped by FDA for sanitary issues and more
Feb 28, 2023 9:40am
Piramal gets FDA resolution in KY; begins production in MI
Feb 16, 2023 10:32am
Troubled Torrent plant gets FDA 'official action' letter
Jan 24, 2023 9:00am
Sovereign Pharma snaps up Monarch site in bankruptcy sale
Jan 12, 2023 9:55am
FDA slaps Sun Pharma plant with import alert after inspection
Dec 8, 2022 9:35am
